Evaluation of clinical utility in emulated clinical trials
European Journal of Epidemiology · 2026
DOI: 10.1007/s10654-026-01385-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Epidemiology, 2026. Verfasst von Johannes Hruza und 4 weiteren Autor:innen. Beteiligte Einrichtung: Section of Health Data Science and AI, University of Copenhagen, Copenhagen, Denmark. johannes.hruza@sund.ku.dk. Hauptthemen laut MEDLINE: Clinical Trials as Topic, Precision Medicine. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Copenhagen University.
Abstract (Originalsprache)
Dynamic treatment regimes have been proposed to personalize treatment decisions by utilizing historical patient data, but they may not always improve on the current standard of care. It is thus meaningful to integrate the standard of care into the evaluation of treatment strategies, and previous works have suggested doing so through the concept of clinical utility . Here we will focus on the comparative component of clinical utility as the average outcome had the full population received treatment based on the proposed dynamic treatment regime in comparison to the full population receiving the “standard" treatment assignment mechanism, such as a physician’s choice. Clinical trials to evaluate clinical utility are rarely conducted, and thus, previous works have proposed an emulated clinical trial framework using observational data. However, only one simple estimator was previously suggested, and the practical details of how one would conduct this emulated trial were not detailed. Here, we illuminate these details and propose several estimators of clinical utility based on estimators proposed in the dynamic treatment regime literature. We illustrate the considerations and the estimators in a real data example investigating treatment rules for rheumatoid arthritis, where we highlight that in addition to the standard of care, the current medical guidelines should also be compared to any estimated “optimal” decision rule.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Section of Health Data Science and AI, University of Copenhagen, Copenhagen, Denmark. johannes.hruza@sund.ku.dk.
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
- Section of Biostatistics and the Pioneer Centre for SMART biomed, University of Copenhagen, Copenhagen, Denmark.
- Section of Health Data Science and AI, University of Copenhagen, Copenhagen, Denmark.
- MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.
Förderung
- Copenhagen University
Zitieren
APA
Hruza, J., Sjölander, A., E Gabriel, E., Bhatt, S., & C Sachs, M. (2026). Evaluation of clinical utility in emulated clinical trials. European Journal of Epidemiology. https://doi.org/10.1007/s10654-026-01385-3
Vancouver
Hruza J, Sjölander A, E Gabriel E, Bhatt S, C Sachs M. Evaluation of clinical utility in emulated clinical trials. European Journal of Epidemiology. 2026. doi:10.1007/s10654-026-01385-3
BibTeX
@article{Hruza2026,
author = {Hruza, Johannes and Sjölander, Arvid and E Gabriel, Erin and Bhatt, Samir and C Sachs, Michael},
title = {Evaluation of clinical utility in emulated clinical trials},
journal = {European Journal of Epidemiology},
year = {2026},
doi = {10.1007/s10654-026-01385-3}
}
EUVIMED